Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Applied Neuropsychology. Child
|
May 19, 2016
Working Memory and Neurofeedback
Eric YuLeung To, Kathy Abbott, Dale S Foster, et al.
Pharmacology & Therapeutics
|
March 4, 2021
Cyclic nucleotide phosphodiesterase inhibitors as therapeutic interventions for cystic fibrosis
Mark J Turner, Kathy Abbott-Banner, David Y Thomas, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
December 22, 2021
Phosphodiesterase 8A Regulates CFTR Activity in Airway Epithelial Cells
Mark J Turner, Yukiko Sato, David Y Thomas, et al.
Arthritis and Rheumatism
|
March 1, 2007
RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis
Kelly A Rouster-Stevens, Craig B Langman, Heather E Price, et al.
Pharmaceutical Research
|
January 6, 2022
Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology
Debra Tompson, Mark Whitaker, Rennan Pan, et al.
Arthritis and Rheumatism
|
September 30, 2006
Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation
Lauren M Pachman, Arthur Veis, Stuart Stock, et al.
Pharmaceutical Research
|
June 17, 2021
Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772
Debra J Tompson, Mark Whitaker, Rennan Pan, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 8, 2015
The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia
Mark J Turner, Elizabeth Matthes, Arnaud Billet, et al.
Clinical and Translational Science
|
September 9, 2024
Randomized, placebo-controlled study on the effects of intravenous GSK3858279 (anti-CCL17) on a battery of evoked pain tests in healthy participants
Yvonne Boyle, Hemme J Hijma, Jamie Rees, et al.
BMJ Open Gastroenterology
|
August 14, 2021
A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis
Kathy Weisel, Nicola Scott, Scott Berger, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Applied Neuropsychology. Child
|
May 19, 2016
Working Memory and Neurofeedback
Eric YuLeung To, Kathy Abbott, Dale S Foster, et al.
Pharmacology & Therapeutics
|
March 4, 2021
Cyclic nucleotide phosphodiesterase inhibitors as therapeutic interventions for cystic fibrosis
Mark J Turner, Kathy Abbott-Banner, David Y Thomas, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|
December 22, 2021
Phosphodiesterase 8A Regulates CFTR Activity in Airway Epithelial Cells
Mark J Turner, Yukiko Sato, David Y Thomas, et al.
Arthritis and Rheumatism
|
March 1, 2007
RANKL:osteoprotegerin ratio and bone mineral density in children with untreated juvenile dermatomyositis
Kelly A Rouster-Stevens, Craig B Langman, Heather E Price, et al.
Pharmaceutical Research
|
January 6, 2022
Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology
Debra Tompson, Mark Whitaker, Rennan Pan, et al.
Arthritis and Rheumatism
|
September 30, 2006
Composition of calcifications in children with juvenile dermatomyositis: association with chronic cutaneous inflammation
Lauren M Pachman, Arthur Veis, Stuart Stock, et al.
Pharmaceutical Research
|
June 17, 2021
Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772
Debra J Tompson, Mark Whitaker, Rennan Pan, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
November 8, 2015
The dual phosphodiesterase 3 and 4 inhibitor RPL554 stimulates CFTR and ciliary beating in primary cultures of bronchial epithelia
Mark J Turner, Elizabeth Matthes, Arnaud Billet, et al.
Clinical and Translational Science
|
September 9, 2024
Randomized, placebo-controlled study on the effects of intravenous GSK3858279 (anti-CCL17) on a battery of evoked pain tests in healthy participants
Yvonne Boyle, Hemme J Hijma, Jamie Rees, et al.
BMJ Open Gastroenterology
|
August 14, 2021
A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis
Kathy Weisel, Nicola Scott, Scott Berger, et al.
Page
of 2